KMT2A and leukemia: Therefore, we reasoned that disruption of the balance between wild-type MLL and MLL chimeras plays a critical role in PI resistance, and that targeting MLL dysfunction and restoring MLL may be a promising strategy for treating the aggressive resistance in MLL leukemia.